InvestorLens

BLTE — BELITE BIO INC

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BLTE?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Net distribution · 2 buying vs 2 selling last quarter
39
Macro Tailwind
Macro conditions are mixed for this sector
55
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their BLTE position last quarter, 2 bought and 2 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).

Supporting evidence
  • +2 tracked investors added or increased positions last quarter (Steve Cohen, Ken Griffin)
  • +4 tracked investors reported holding BLTE at their latest filing
  • +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.

About BELITE BIO INC (BLTE)

BELITE BIO INC (BLTE) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $91M. Across recent filings, tracked investors recorded 7 new positions, 7 increased, 2 reduced, and 4 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BLTE

70
/100
Institutional Accumulation
Added / Increased14
Reduced2
Exited4
BearishBullish
Crowded Trade Score™

How many top investors track BLTE

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

BLTE Ownership Composition

How BELITE BIO INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
87% of tracked value
Institutions
4
tracked investors
Total Reported
$129M
combined 13F value
Types2
  • Multi-Strategy / Quant87.3%
  • Macro12.7%
Multi-Strategy / Quant(3)
87.3%
Macro(1)
12.7%

Tracked investors currently reporting BLTE

1 tracked investor has since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    494.6K
    Value
    $76.2M
    % Portfolio
    0.03%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    51.2K
    Value
    $7.9M
    % Portfolio
    0.01%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    186.2K
    Value
    $28.7M
    % Portfolio
    0.00%
  • Stanley DruckenmillerJun 30, 2026
    Duquesne Family Office
    Shares
    106.1K
    Value
    $16.3M
    % Portfolio
    0.31%

Previously held BLTE

These investors reported BLTE in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Paul Tudor JonesTudor Investment Corp1.6K$254.5KMar 31, 2026

Recent activity

Frequently asked questions

How many institutional investors hold BLTE?
4 tracked institutional investors disclosed a position in BLTE (BELITE BIO INC) in their most recent 13F filing.
Who is the largest institutional holder of BLTE?
Izzy Englander, Millennium Management, holds the largest disclosed position in BLTE, valued at $91M.
Did institutional ownership of BLTE increase or decrease?
Across recent 13F filings, tracked investors recorded 7 new positions, 7 increased, 2 reduced, and 4 fully exited BLTE.
Where does this BLTE ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.